Given the considerable detrimental impact of NACT on survival among non-pCR patients, a logistic regression model was employed to identify the predictive factors for non-pCR in T2N1M0 stage HR + /HER2- breast cancer patients after undergoing NACT. The gene discussed is ERBB2; the disease is breast carcinoma.